InvestorsHub Logo

couldbebetter

05/07/20 10:22 AM

#271818 RE: zumantu #271811

zumantu, Agree 100%! Time is so critically important here. If there
were any substantiated benefit from Vascepa with COVID-19 or its
after effects, BP would acquire AMRN and tie up all raw material
feed stock to choke off any possibility of generic threat.
BP can do that...AMRN cannot!